J. Pinkert

Radiopharmaceutical tracking of particles injected into tumors: a model to study clearance kinetics.

W. Luboldt, J. Kotzerke, G. Wunderlich, 2009, Current drug delivery.

Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.

G. Folprecht, J. Kotzerke, C. Brogsitter, 2007, Japanese journal of clinical oncology.

Assessment of the radiation exposure of relatives and caregivers of patients treated with Ra-223 - Results of a German multicenter study.

L. Geworski, J. Pinkert, C. Wanke, 2020, Zeitschrift fur medizinische Physik.

Therapeutic status of radiosynoviorthesis of the knee with yttrium [90Y] colloid in rheumatoid arthritis and related indications.

A. Krause, M. Voth, W. Kampen, 2007, Rheumatology.

Radiosynoviorthesis of medium-sized joints with rhenium-186-sulphide colloid: a review of the literature.

M. Voth, U. Lange, R. Klett, 2007, Rheumatology.

The effect of the β-emitting yttrium-90 citrate on the dose–response of dicentric chromosomes in human lymphocytes: a basis for biological dosimetry after radiosynoviorthesis

M. Haney, F. Gildehaus, M. Voth, 2006, Radiation and environmental biophysics.

Rhenium Radioisotopes for Therapeutic Radiopharmaceutical Development

F. Knapp, Wan-Yu Lin, J. Kropp, 1999 .

Thorium-227-Labeled Anti-CD22 Antibody (BAY 1862864) in Relapsed/Refractory CD22-Positive Non-Hodgkin Lymphoma: A First-in-Human, Phase I Study.

D. Cunningham, A. Cleton, I. Sturm, 2021, Cancer biotherapy & radiopharmaceuticals.